Mayo Clinic seeks men concerned with prostate health for clinical trial

Wednesday, September 22, 2004

JACKSONVILLE, Fla., Sept. 22, 2004 — Doctors from the Mayo Clinic Department of Urology are seeking to enroll men with prostate problems into a clinical research study. This study is testing the safety and effectiveness of an investigational use of an FDA-approved drug in reducing the risk of prostate cancer.

Men must be 50 to 75 years old and may suffer symptoms such as difficulty urinating and a frequent urge to urinate. Participants must have had only one negative prostate biopsy that must have occurred within the last six months. Volunteers meeting these and other criteria will be asked to undergo a screening visit to determine eligibility.

"This comprehensive study is exciting because it allows us to look at the potential of a complete hormone blockade drug on possibly preventing prostate cancer," says Dr. Todd Igel, the study's chief investigator and a Mayo Clinic urologist.

In addition to the screening visit, participants will be asked to complete approximately nine scheduled clinic visits during the course of the four-year study. All office visits and medical evaluations related to this study will be provided to qualified participants at no charge. Eligible participants may also be reimbursed for their travel and certain other study-related expenses.

For more information, please call (904) 953-0871.

— 30 —

Mayo Clinic is a multispecialty medical clinic in Jacksonville, Fla. The staff includes 328 physicians working in more than 40 specialties to provide diagnosis, treatment and surgery. Patients who need hospitalization are admitted to nearby St. Luke's Hospital, a 289-bed Mayo facility. Mayo Clinics also are located in Rochester, Minn., and Scottsdale, Ariz. Visit www.mayoclinic.org/news for all the news from Mayo Clinic.

###

To obtain the latest news releases from Mayo Clinic, go to www.mayoclinic.org/news. MayoClinic.com is available as a resource for your health stories.